IART · Company research
Integra LifeSciences Holdings (IART): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| New research on balloon treatment alongside surgery for chronic ear disease will be presented - Stock Titan | New research on balloon treatment alongside surgery for chronic ear disease will be presented Stock Titan | View source ↗ | Stock Titan | Oct 16, 2026 | neutral | 0 | 0.6 |
| Integra Lifesciences Holdings Corp (IART) Shares Surge 4.0% -- W - GuruFocus | Integra Lifesciences Holdings Corp (IART) Shares Surge 4.0% -- W GuruFocus | View source ↗ | GuruFocus | Oct 13, 2026 | neutral | 0 | 0.6 |
| Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History - Yahoo! Finance Canada | Integra LifeSciences Holdings Corporation (IART) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% G - GuruFocus | A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% G GuruFocus | View source ↗ | GuruFocus | Oct 9, 2026 | neutral | 0 | 0.6 |
| Integra LifeSciences Holdings (IART) Cuts 2026 Revenue Outlook, Is The Stock Below Fair Value? - Yahoo Finance | Integra LifeSciences Holdings (IART) Cuts 2026 Revenue Outlook, Is The Stock Below Fair Value? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART) - PR Newswire | Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART) PR Newswire | View source ↗ | PR Newswire | Oct 2, 2026 | neutral | 0 | 0.6 |
| Why Integra LifeSciences (IART) Stock Is Nosediving - Yahoo Finance | Why Integra LifeSciences (IART) Stock Is Nosediving Yahoo Finance | View source ↗ | Yahoo Finance | Oct 2, 2026 | neutral | 0 | 0.6 |
| Stock Market Midday, Oct. 2: Stocks Rally as Weak Jobs Data Cools Fed Rate Hike Bets | U.S. stock markets rallied on October 2, 2026, following weaker-than-expected September employment data showing only 29,000 jobs added and unemployment rising to 4.2%. The soft labor report reduced expectations for a Federal Reserve rate hike this month from 64% to 21%, boosting investor sentiment particularly in tech and growth stocks. The Nasdaq Composite hit a record high, while the S&P 500 and Dow Jones also gained. | View source ↗ | The Motley Fool | Oct 2, 2026 | bullish | 0.6 | 1 |
| Stock Market Midday, Oct. 2: Stocks Rally as Weak Jobs Data Cools Fed Rate Hike Bets | U.S. stock markets rallied on October 2, 2026, following weaker-than-expected September employment data showing only 29,000 jobs added and unemployment rising to 4.2%. The soft labor report reduced expectations for a Federal Reserve rate hike this month from 64% to 21%, boosting investor sentiment particularly in tech and growth stocks. The Nasdaq Composite hit a record high, while the S&P 500 and Dow Jones also gained. | View source ↗ | The Motley Fool | Oct 2, 2026 | bullish | 0.6 | 1 |
| A July flood is expected to cut Integra's fourth-quarter revenue by about $15-$20 million - Stock Titan | A July flood is expected to cut Integra's fourth-quarter revenue by about $15-$20 million Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| $450 million in Integra LifeSciences notes carry a 9.5% rate - Stock Titan | $450 million in Integra LifeSciences notes carry a 9.5% rate Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Why Integra LifeSciences (IART) Stock Is Nosediving - TradingView | Why Integra LifeSciences (IART) Stock Is Nosediving TradingView | View source ↗ | TradingView | Oct 2, 2026 | neutral | 0 | 0.6 |
| IART vs. PEN: Which Stock Is the Better Value Option? | In a comparison of two medical instruments sector stocks, Integra LifeSciences (IART) emerges as the better value opportunity for investors compared to Penumbra (PEN). IART has a Zacks Rank of #2 (Buy) with a forward P/E of 6.62 and Value grade of B, while PEN has a Zacks Rank of #3 (Hold) with a forward P/E of 64.18 and Value grade of D. IART's superior valuation metrics and improving earnings outlook make it the more attractive choice for value investors. | View source ↗ | Zacks Investment Research | Oct 1, 2026 | neutral | 0 | 1 |
| IART vs. PEN: Which Stock Is the Better Value Option? | In a comparison of two medical instruments sector stocks, Integra LifeSciences (IART) emerges as the better value opportunity for investors compared to Penumbra (PEN). IART has a Zacks Rank of #2 (Buy) with a forward P/E of 6.62 and Value grade of B, while PEN has a Zacks Rank of #3 (Hold) with a forward P/E of 64.18 and Value grade of D. IART's superior valuation metrics and improving earnings outlook make it the more attractive choice for value investors. | View source ↗ | Zacks Investment Research | Oct 1, 2026 | neutral | 0 | 1 |
| Should You Continue to Hold IART Stock in Your Portfolio? - TradingView | Should You Continue to Hold IART Stock in Your Portfolio? TradingView | View source ↗ | TradingView | Sep 30, 2026 | neutral | 0 | 0.6 |
| Should You Continue to Hold IART Stock in Your Portfolio? - Yahoo Finance | Should You Continue to Hold IART Stock in Your Portfolio? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 30, 2026 | neutral | 0 | 0.6 |
| A registry tracking an ear treatment for children has enrolled 100 of its planned 300 patients. - Stock Titan | A registry tracking an ear treatment for children has enrolled 100 of its planned 300 patients. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| IART or PEN: Which Is the Better Value Stock Right Now? - Yahoo Finance | IART or PEN: Which Is the Better Value Stock Right Now? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 29, 2026 | neutral | 0 | 0.6 |
| Integra LifeSciences (IART) Stock May Be 48% Undervalued On Cash Flow - Yahoo Finance | Integra LifeSciences (IART) Stock May Be 48% Undervalued On Cash Flow Yahoo Finance | View source ↗ | Yahoo Finance | Sep 22, 2026 | neutral | 0 | 0.6 |
| IART Stock Surges 52.1% in a Year: What's Driving the Rally? - Yahoo Finance | IART Stock Surges 52.1% in a Year: What's Driving the Rally? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 15, 2026 | neutral | 0 | 0.6 |
| Why Integra LifeSciences (IART) Stock Is Up Today - Yahoo Finance | Why Integra LifeSciences (IART) Stock Is Up Today Yahoo Finance | View source ↗ | Yahoo Finance | Jul 9, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.